# A Study of SPY003-207 in Healthy Volunteers

> **NCT06873724** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Spyre Therapeutics, Inc.** · enrollment: 59 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** SPY003-207
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06873724
- **Lead sponsor:** Spyre Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-10
- **Primary completion:** 2026-11-18
- **Final completion:** 2026-11-18
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2026-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06873724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06873724, "A Study of SPY003-207 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06873724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*